NCT00406445View on ClinicalTrials.gov

Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

January 23, 2007

Primary Completion Date

March 22, 2021

Study Completion Date

March 22, 2021

Conditions
Mitochondrial DisordersLi-Fraumeni SyndromeCarriers of p53 Mutation
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00406445 - Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni Syndrome | Biotech Hunter | Biotech Hunter